window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : July 20, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Artificial intelligence

  • Digital & Data,Drug Discovery & Development,Research & Development

    Latent Labs opens lab-validated AI drug design platform to researchers worldwide

    Latent Labs has launched its artificial intelligence-powered drug design platform [...]

    July 15, 2026
  • Digital & Data,Drug Discovery & Development,Research & Development,Therapeutic Areas

    Nucs AI taps Segmed’s 150 million imaging studies to strengthen oncology AI

    Nucs AI has partnered with healthcare data specialist Segmed to [...]

    July 15, 2026
  • Digital & Data,Research & Development,Therapeutic Areas

    Fleming Initiative selects AWS to support global antimicrobial resistance platform

    The Fleming Initiative has selected Amazon Web Services (AWS) to [...]

    July 3, 2026
  • Digital & Data,Drug Discovery & Development,Research & Development

    Basecamp integrates AI antibiotic and vaccine design models into Claude Science

    Basecamp Research has integrated its EDEN antibiotic design and vaccine [...]

    July 2, 2026
  • Biotech & Pharma Business,Digital & Data

    Veeva acquires Copli and launches AI-powered content review platform

    Veeva Systems has acquired Copli and launched a new AI-powered [...]

    June 25, 2026
  • Clinical & Regulatory,Digital & Data

    Kayentis launches AI-powered eConsent tool for clinical trials

    Kayentis has launched an AI-powered eConsent module designed to improve [...]

    June 25, 2026
  • Digital & Data

    AI adoption grows in life science labs but data integration remains a barrier, survey finds

    More than 60% of life science laboratories are exploring or [...]

    June 19, 2026
  • Digital & Data,Genomics and sequencing

    Wellcome Genome Campus expands AI and genomics ambitions with new advisory group

    The Wellcome Genome Campus has established a Science and Technology [...]

    June 18, 2026
  • Digital & Data,Drug Discovery & Development

    Sygnature Discovery partners with DaltonTx to expand AI drug discovery capabilities

    Sygnature Discovery has entered into a strategic collaboration with AI [...]

    June 11, 2026
  • Digital & Data,Drug Discovery & Development

    Medable launches programme to support AI deployment in clinical development

    Medable has launched a new support programme aimed at helping [...]

    June 9, 2026
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • PET imaging reveals widespread synaptic loss in schizophrenia
    Categories: Clinical & Regulatory, Research & Development, Therapeutic Areas
  • Revita maintains GLP-1 weight loss one year after treatment discontinuation in REMAIN-1 trial
    Categories: Clinical & Regulatory, Medical devices, Pharmaceuticals and therapeutics, Research & Development
  • Two-minute digital test matches clinical benchmarks for Alzheimer’s trial screening
    Categories: Clinical & Regulatory, Digital & Data, Research & Development, Therapeutic Areas
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top